High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma

Lianne M. Haveman, Willemijn B. Breunis, Elvira C. van Dalen, Leontien C.M. Kremer, Heribert Jürgens, Uta Dirksen, Henk van den Berg, Johannes H.M. Merks

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

Samenvatting

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of HDC with AHCT versus standard-dose chemotherapy in improving event-free survival, overall survival, quality adjusted survival and progression-free survival of children, adolescents and young adults with first recurrence of ES and to determine the toxicity of the treatment.

Originele taal-2Engels
ArtikelnummerCD011406
TijdschriftCochrane Database of Systematic Reviews
Volume2014
Nummer van het tijdschrift12
DOI's
StatusGepubliceerd - 6 dec. 2014
Extern gepubliceerdJa

Vingerafdruk

Duik in de onderzoeksthema's van 'High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma'. Samen vormen ze een unieke vingerafdruk.

Citeer dit